Nascent Pharma Hldgs Inc.

13F holders, Q4 2025 (December 31)
1holders
$0.00avg. 13F price*

At the end of Q4 2025, 1 institutions reported holding Nascent Pharma Hldgs Inc. in their 13F filings. The largest holder was Byrne Asset Management LLC ($0).

Company
Nascent Pharma Hldgs Inc.
CUSIP
64120S109
Latest filing quarter
Q4 2025

Total Exit/New Position Q4 2025

InstitutionsTotal Value
New Positions1$0
Exits0$0

Ownership 1 holders

Byrne Asset Management LLC 0.00% New 12 $0

"% of holder's portfolio" is NASCENT PHARMA HLDGS INC's weight in each manager's 13F, not the share of Nascent Pharma Hldgs Inc. the manager owns.